Anavex Life Sciences Corp.
AVXLNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $126.34M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.14$9.50
- Volume (live)
- -
- Avg. volume (3M)
- 1.25M
Anavex Life Sciences (AVXL) Stock Price & Financial Analysis
Anavex Life Sciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.33 - $1.41 |
|---|---|
| 52-Week High | $9.50 |
| 52-Week Low | $1.14 |
| Open | $1.33 |
| Volume (last close) | 1.01M |
| Average Volume (3M) | 1.25M |
| 50-Day MA | $2.46 |
|---|---|
| 200-Day MA | $3.21 |
| 1-Year Change | −84.44% |
| Market Cap | 126.34M |
|---|---|
| Shares Outstanding | 92.90M |
| Price to Book (P/B) | 1.12 |
| EV/EBITDA | -0.62 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Anavex Life Sciences at a Glance
As of the Oct 22, 2026 close, Anavex Life Sciences (AVXL) has a market capitalization of $126.34M.
As of its latest reported balance sheet, it holds $118.33M in cash and securities against $0.00 of debt, a net cash position of $118.33M.
Anavex Life Sciences does not currently pay a dividend.
The share price is down 84.4% over the past year. At $1.36 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $1.14 to $9.50, below its 200-day moving average of $3.21.
Frequently Asked Questions About Anavex Life Sciences
What is the current stock price for AVXL?
As of the Oct 22, 2026 close, AVXL stock trades at $1.36. The 52-week range is $1.14–$9.50, with a day range of $1.33–$1.41.
What is the P/E ratio for AVXL?
The P/E ratio (Price-to-Earnings) for AVXL is shown in the Key Statistics section. This valuation metric helps compare Anavex Life Sciences Corp. to industry peers.
Does AVXL pay dividends?
Anavex Life Sciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for AVXL?
Analyst ratings and recommendations for AVXL are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of AVXL?
As of the Oct 22, 2026 close, Anavex Life Sciences's market capitalization is $126.3M, classifying it as a micro-cap company. Anavex Life Sciences operates in the Healthcare sector within the Biotechnology industry.